CTLA4 and neoplasm: Soluble immunosuppressive mediators, including transforming growth factor beta and indolamine 2,3-dioxygenase (IDO), immune regulatory cells, receptor/ligand expression on tumor cells such as CTLA-4 and PD-1/PD-1L and tumor-derived exosomes all serve to dampen T cell activity (reviewed in [6]).